This bill amends provisions related to medical cannabis.
This bill:
- exempts medical cannabis processors from obtaining an additional license to process cannabinoid (hemp) products;
- creates a fee on medical cannabis purchases for use in enforcement of various laws;
- renames the Cannabis Production Establishment and Pharmacy Licensing Advisory Board to the Specialized Product Authority Licensing Board (licensing board);
- reconstitutes the licensing board's membership;
- amends provisions related to labeling and packaging;
- modifies the licensing board's duties;
- moves control of the Qualified Patient Enterprise Fund to the Department of Agriculture and Food;
- allows medical cannabis processors to make cannabis products with a THC content below .3% (low THC products);
- allows medical cannabis pharmacies to sell low THC products; and
- allows any patient to obtain a medical cannabis patient card from a recommending medical provider through a virtual visit.

Statutes affected:
Introduced: 4-41-103.2, 26B-4-201, 26B-4-213, 26B-4-214, 26B-4-219, 26B-4-222